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Cowden syndrome (CS) is an autosomal dominant disorder characterized by presence of multiple hamartomas, and other benign
andmalignant abnormalities of the breasts, skin, thyroid, endometrium, gastrointestinal tract, and central nervous system. Hamar-
tomas are benign, developmentally disorganized tumors that can develop in any of the above mentioned organs. The presence
of massive calcifications in the breasts in very young women is an indication to perform a breast MRI to exclude a neoplasm
since, like in the current case report, presence of breast calcifications may obscure a neoplasm. Although fibrocystic disease and
cooccurrence of fibrocystic disease and breast cancer are muchmore common than CS, the presence of massive calcifications in the
breasts of very young women should elicit the possibility of an underlying genetic disease. Furthermore, breast cancer and macro-
cephaly are considered major criteria for the diagnosis of CS and the combination of both is enough to establish the clinical diag-
nosis of this entity. Fibrocystic disease of the breasts and multinodular goiter are minor criteria. Family history is also important
for the diagnosis of (any) hereditary disease.
This work was dedicated to Professor Dr. Carla Boetes (1949–2011).
1. Case Report
A 26-year-old woman was diagnosed with breast cancer from
biopsy of an axillary lymph node. An ultrasound (Figure 1)
followed by an MRI of the breasts (Figures 2 and 3) were
subsequently performed.
The patient underwent annual breast ultrasound because
of a family history of breast cancer. In addition, she had
a history of multinodular goiter. By physical examination,
it was also apparent that she had a relatively large head in
relation to her length (length 170 cm and head circumference
61 cm, i.e., above 97th percentile). According to the patient,
macrocephaly is a common feature in her family. Family
history also revealed that the patient’s mother had breast
cancer at the age of 45. The patient’s identical twin is known
to have breast fibrocystic disease (Figure 4).
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Figure 1: Ultrasound shows multiple, ill-defined hypoechoic areas
with acoustic shadowing, indicating multiple coarse calcifications
within the right breast (arrows).
In Figure 1, the ultrasound shows multiple, ill-defined
hypoechoic areas with acoustic shadowing, indicating mul-
tiple coarse calcifications within the right breast. In Figure 2,
transverse T2-weighted magnetic resonance images show
multiple coarse calcifications in both breasts and a large, lob-
ulated mass in the lower lateral quadrant of the right breast.
Contrast-enhanced subtraction MR images (Figure 3(a)) and
T1-weighted images (Figure 3(b)) show a large, macrolob-
ulated enhancing mass with irregular margins in the lower
lateral quadrant of the right breast. Finally, her sister’s mam-
mography (mediolateral oblique direction shown) showed
massive calcifications in multiple, well-defined masses, some
of them with adipose tissue, diagnostic of hamartomas.
Biopsy results showed that the patient had a locally
advanced, invasive, well-diﬀerentiated ductal carcinoma in
the right breast which was obscured on annual ultrasound
due to massive calcifications by hamartomas.
The radiological images, together with the thyroid patho-
logy and macrocephaly, suggested Cowden syndrome (CS)
as most likely underlying cause, which was later confirmed
by identification of a germline splice-site mutation: c.634 +
2T > C in intron 6 of the PTEN gene. The mutation was
inherited from the patient’s mother.
The patient was treated with neoadjuvant chemotherapy
with a partial response, followed by a modified radical mas-
tectomy and preventive contralateral mastectomy, and by
(a)
(b)
Figure 2: Transverse T2-weighted images show multiple coarse cal-
cifications in both breasts ((a) small arrows) and a large, lobulated
mass in the lower lateral quadrant of the right breast ((b) white
arrow).
(a)
(b)
Figure 3: Contrast-enhanced (subtraction) MR images (a) and
contrast-enhanced T1-weighted MR images (b) show a large, lobu-
lated heterogeneously enhancing mass with irregular borders in the
lower lateral quadrant of the right breast (arrows).
locoregional radiotherapy (because of 5 positive axillary
lymph nodes) plus adjuvant endocrine therapy.
2. Discussion
The presence of massive calcifications in the breasts in a very
young woman is a plausible indication to perform an breast
MRI to exclude a neoplasm since, like it was the case in
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Figure 4: Patient’s sister mammography (mediolateral oblique
direction shown) showed massive calcifications in multiple, well-
defined masses, some of them with adipose tissue, diagnostic of
hamartomas.
our patient, the presence of breast calcifications may obscure
a neoplasm. Although fibrocystic disease and co-occurrence
of fibrocystic disease and breast cancer are much more com-
mon than CS (which has an estimated prevalence between
1/200,000 and 1/250,000 in the Dutch population [1]), the
presence of massive calcifications in the breasts of very young
women should elicit the possibility of an underlying genetic
disease. Furthermore, breast cancer and macrocephaly are
considered major criteria for the diagnosis of CS and the
combination of both is enough to establish the clinical diag-
nosis of this entity [2]. Fibrocystic disease of the breasts and
multinodular goiter are minor criteria [2]. Family history is
also important for the diagnosis of (any) hereditary disease.
Cowden syndrome, OMIM# 158350 [3], first described
in 1963 by Lloyd and Dennis in a patient called Rachel Cow-
den [4], is also known as multiple hamartoma syndrome. It
is an autosomal dominant disorder characterized by presence
of multiple hamartomas, and other benign and malignant
abnormalities of the breasts, skin, thyroid, endometrium,
gastro intestinal tract, and central nervous system. Hamar-
tomas are benign, developmentally disorganized tumors that
can develop in any of the above mentioned organs [5, 6].
The National Comprehensive Cancer Network (NCCN)
has established diagnostic criteria for CS, based on combi-
nations of features classified as pathognomonic, major, and
minor [2]. There are two pathognomonic criteria: a cere-
bellar tumor known as dysplastic gangliocytoma that causes
a range of symptoms derived from compression, known as
Lhermitte-Duclos disease, and the following mucocutaneous
lesions: facial trichilemmomas, acral keratoses, and papillo-
matous nodules. Major criteria are: breast carcinoma, non-
medullary thyroid carcinoma, macrocephaly, and endome-
trial carcinoma. Minor criteria are: other thyroid lesions,
mental retardation, gastrointestinal hamartomas, fibrocystic
disease of the breast, lipomas, fibromas, tumors or struc-
tural malformations in the genitourinary tract and uterine
fibroids.
Operational diagnosis of CS in an individual is done
when the patient has any of the following: (1) presence of any
pathognomonic lesion (by mucocutaneous lesions a certain
number and/of combinations of these lesions are required);
(2) two or more major criteria (but one has to be macro-
cephaly); (3) one major and three minor criteria, or (4) four
minor criteria [2].
A mutation in PTEN (PTEN = phosphatase and tensin
homologue), a tumor suppressor gene, is found in more
than 80% of patients who fulfill these criteria [5]. So far,
no genotype/phenotype correlations have been found among
the patients with CS [1, 5].
In addition to CS, germline PTEN mutations have been
associated with the following syndromes, globally known
as PTEN hamartoma tumor syndromes (PHTS): Bannayan-
Riley-Ruvalcaba syndrome (BRRS), Proteus, Proteus-like
syndrome, adult Lhermite Duclos disease, and autism-like
disorders associated withmacrocephaly [6]. Of those entities,
CS and BRRS (OMIM# 153480) [2] have the highest degree
of clinical overlap, such as fibrocystic disease, macrocephaly,
thyroid disease, lipomas, intestinal hamartomatous polyps,
and mental retardation. BRRS is nowadays considered a var-
iant of CS rather than a separate entity.
Breast cancer is the most frequent malignancy of CS. It
occurs in 30–50% of patients, with an average age of diag-
nosis between 38 and 46 years, with the youngest reported
case at age 14. Risk of bilateral breast cancer is estimated to be
25% [5, 6]. Like in the general population, ductal carcinoma
is the most frequent histological type. However, the finding
of hyalinized collagen surrounding the tumor is specific for
CS [5]. Breast hamartomas are benign lesions and are often
radiologically and morphologically indistinguishable from
fibroadenomas. They are seen in areas of the breast with a
combination of fat, fibrous, and muscular tissues, but, can
also appear as ill-defined calcified masses suspicious of a
malignancy [7]. Although hamartomas and carcinoma can
colocalize, as it was the case in our patient, it is not clear
whether the carcinoma arises from a hamartoma.
Although breast MRI examinations, only represent a
small percentage of the MRI examinations performed, its
use is growing rapidly. MRI is more sensitive than mammo-
graphy in detecting tumors in women with an inherited
predisposition due to mutation in BRCA1, BRCA2, PTEN or
TP53 genes [8]. However, MRI does not substitute mammo-
graphy, that is, mammography is better to detect ductal
carcinoma in situ and some small cancers. In 2007, the
American Cancer Society published recommendations for
breastMRI screening [9]. CS is one of the entities where there
is enough evidence to recommend performing annual breast
MRI in combination with mammography. Specific recom-
mendations for womenwith CS include: semiannual physical
breast examination, starting at age 25, annual mammogra-
phy, and breast MRI beginning at age 30–35 or 5–10 years
before the earliest diagnosis, as well as self-examination start-
ing at age 18. Recommendations in The Netherlands [10]
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diﬀer from those above in that women with CS are advised to
undergo an annual MRI from age 25 and the annual mam-
mogram is added from age 30. Prophylactic mastectomy is
also an option for patients with CS and should be considered
on a case-by-case basis. Both men and women are advised
annual clinical examination of the thyroid gland, starting at
age 18.
In conclusion, when massive breast calcifications in
mammograms of young women are observed, the diagnosis
of CS has to be considered. A breast MRI is indicated in those
cases to exclude a neoplasm.
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